150 related articles for article (PubMed ID: 7005917)
1. Psoralen photochemistry.
Parsons BJ
Photochem Photobiol; 1980 Dec; 32(6):813-21. PubMed ID: 7005917
[No Abstract] [Full Text] [Related]
2. DNA repair synthesis in human skin exposed to ultraviolet radiation used in PUVA (psoralen and UV-A) therapy for psoriasis.
Bishop SC
Br J Dermatol; 1979 Oct; 101(4):399-405. PubMed ID: 508605
[TBL] [Abstract][Full Text] [Related]
3. PUVA (psoralen + UVA) photochemotherapy: processes triggered in the cells.
Zarebska Z; Waszkowska E; Caffieri S; Dall'Acqua F
Farmaco; 2000 Aug; 55(8):515-20. PubMed ID: 11132728
[TBL] [Abstract][Full Text] [Related]
4. Topical application of 3-carbethoxypsoralen plus UVA in the treatment of psoriasis.
Kimura S; Mizuno N; Hirano S; Yoshikawa K
J Dermatol; 1985 Jun; 12(3):251-7. PubMed ID: 3908528
[No Abstract] [Full Text] [Related]
5. Psoralen photochemotherapy for vitiligo.
Grimes PE
Clin Dermatol; 1997; 15(6):921-6. PubMed ID: 9404695
[No Abstract] [Full Text] [Related]
6. Effects of oral methoxy-psoralen photochemotherapy (PUVA) on liver function and antipyrin kinetics.
Chretien P; Galmiche JP; Payenneville JM; Fouin-Fortunet H; Lauret P; Boismare F; Colin R
Int J Clin Pharmacol Res; 1983; 3(5):343-7. PubMed ID: 6678827
[TBL] [Abstract][Full Text] [Related]
7. Systemic lupus erythematosus: association with psoralen--ultraviolet-A treatment of psoriasis.
Eyanson S; Greist MC; Brandt KD; Skinner B
Arch Dermatol; 1979 Jan; 115(1):54-6. PubMed ID: 760658
[TBL] [Abstract][Full Text] [Related]
8. Guidelines for topical PUVA: a report of a workshop of the British photodermatology group.
Halpern SM; Anstey AV; Dawe RS; Diffey BL; Farr PM; Ferguson J; Hawk JL; Ibbotson S; McGregor JM; Murphy GM; Thomas SE; Rhodes LE
Br J Dermatol; 2000 Jan; 142(1):22-31. PubMed ID: 10651690
[TBL] [Abstract][Full Text] [Related]
9. Aspects of psoralen phototumorigenesis with emphasis on the possible role of tumour promotion.
Young AR
Biochimie; 1986 Jun; 68(6):885-9. PubMed ID: 3019437
[TBL] [Abstract][Full Text] [Related]
10. Genetic toxicity of psoralen and ultraviolet radiation in human cells.
Bredberg A
Acta Derm Venereol Suppl (Stockh); 1982; 104():1-40. PubMed ID: 6961722
[No Abstract] [Full Text] [Related]
11. Cell membrane, a target for PUVA therapy.
Zarebska Z
J Photochem Photobiol B; 1994 May; 23(2-3):101-9. PubMed ID: 8040751
[TBL] [Abstract][Full Text] [Related]
12. Histologic observations of the lenses of psoralen + UVA treated albino rats and a theory as to the underlying mechanism.
Jose JG; Koch HR; Respondek A
Graefes Arch Clin Exp Ophthalmol; 1982; 219(1):44-53. PubMed ID: 7117861
[TBL] [Abstract][Full Text] [Related]
13. Psoralen therapy in vitiligo.
Ortonne JP
Clin Dermatol; 1989; 7(2):120-35. PubMed ID: 2667737
[No Abstract] [Full Text] [Related]
14. Re-PUVA.
Lassus A
Photodermatol; 1984 Dec; 1(6):263-4. PubMed ID: 6533618
[No Abstract] [Full Text] [Related]
15. Cutaneous phototoxicity due to psoralens.
Gange RW; Parrish JA
Natl Cancer Inst Monogr; 1984 Dec; 66():117-26. PubMed ID: 6531018
[TBL] [Abstract][Full Text] [Related]
16. Detection of DNA-psoralen photoadducts in mammalian skin.
Pathak MA; Zarebska Z; Mihm MC; Jarzabek-Chorzelska M; Chorzelski T; Jablonska S
J Invest Dermatol; 1986 Mar; 86(3):308-15. PubMed ID: 2427607
[TBL] [Abstract][Full Text] [Related]
17. Carcinogenic risk of psoralen plus ultraviolet radiation therapy: evidence in humans.
Stern RS
Natl Cancer Inst Monogr; 1984 Dec; 66():211-6. PubMed ID: 6531032
[TBL] [Abstract][Full Text] [Related]
18. Psoralens, UVA (PUVA) and photocarcinogenesis.
Grekin DA; Epstein JH
Photochem Photobiol; 1981 Jun; 33(6):957-60. PubMed ID: 7025050
[No Abstract] [Full Text] [Related]
19. PUVA--lentigo.
Kanerva L; Lauharanta J
Photodermatol; 1985 Apr; 2(2):49-51. PubMed ID: 2412214
[No Abstract] [Full Text] [Related]
20. Photochemotherapy: a new promising chemical derivative.
Willis I
Arch Dermatol Res; 1982; 272(3-4):251-6. PubMed ID: 7165333
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
